WHO Public Assessment Reports (WHOPARs) published
M
Medopharm’s chewable albendazole tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
- NT012 Albendazole Tablets, Chewable 400mg – Medopharm - INDIA
Active Pharmaceutical Ingredient (API) Prequalified
M
Dihydroartemisinin manufactured by Guilin Pharmaceutical Co., Ltd.
Mylan’s nirmatrelvir + ritonavir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
MSN Laboratories’ bedaquiline tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
TB395 Bedaquiline fumarate Tablet 100mg - MSN Lab - INDIA